Call Options Transactions Made in Q2 2023 in Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT) during Q2 2023. The information is specifically focused on institutions that hold call options of Arcutis Biotherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
87.9K+ 320.8% |
$660K - $1.32M
|
115K
$1.63M
|
|
|
Aug 14, 2023
Q2 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
65K+ 92.86% |
$488K - $975K
|
135K
$1.9M
|
|
|
Aug 14, 2023
Q2 2023
|
Symmetry Investments LP
|
BUY
|
CALL |
31.5K+ 117.98% |
$237K - $473K
|
58.2K
$821K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
20.7K+ 116.95% |
$155K - $311K
|
38.4K
$542K
|
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
CALL |
11.6KNew |
$87.1K - $174K
|
11.6K
$164K
|
|
|
Aug 14, 2023
Q2 2023
|
Centiva Capital, LP
New York, NY |
BUY
|
CALL |
100New |
$751 - $1.5K
|
100
$1.41K
|
|
|
Aug 14, 2023
Q2 2023
|
Parallax Volatility Advisers, L.P.
San Francisco, CA |
SELL
|
CALL |
-152K- 97.63% |
$1.14M - $2.28M
|
3.7K
$52.2K
|